2025 Year In Review: Entering An Era Of Sustained Growth
Today, we launch Almirall’s 2025 Year in Review, a comprehensive publication that looks back on a transformative year and captures the key achievements that shaped our progress throughout 2025. The Year in Review offers a structured and transparent overview of a year defined by accelerated growth, strategic clarity, and a strengthened leadership position in medical dermatology.
Throughout 2025, we continued to advance our growth trajectory in line with our ambition to lead medical dermatology. The Year in Review reflects how this ambition translated into concrete results: the continued expansion of a differentiated dermatology portfolio, steady progress across an exciting R&D pipeline of innovative assets, and strong commercial execution. Together, these elements enabled us to meet our financial guidance while delivering sustained double‑digit sales growth and margin expansion.
Beyond performance, the 2025 Year in Review provides a broader perspective on the drivers behind these results. Readers will find an overview of the year, together with the major milestones that marked the year and a letter from our CEO outlining the strategic context and long‑term direction. The publication also explores how we continue transforming patients’ lives through our portfolio and key products, and how close partnerships with dermatologists remain central to our approach.
In addition, the Year in Review includes a detailed chapter on our financial performance, complemented by insights into our financial outlook and stock performance. It also highlights our focus on innovation as a key enabler of sustainable growth, alongside our continued commitment to sustainability and to the principles of corporate governance that guide responsible decision‑making and long‑term value creation.
By bringing together business results, strategy, innovation, and impact, the 2025 Year in Review captures how 2025 laid solid foundations for the future and reinforces our commitment to advancing medical dermatology through science, innovation, and partnerships.